Brief: Amarin Announces Vazkepa® (Icosapent Ethyl) Approved By Medsafe In New Zealand
27/01/2023 14:14
Jan 27 (Reuters) - Amarin Corporation PLC AMRN.O :
* AMARIN ANNOUNCES VAZKEPA® (ICOSAPENT ETHYL) APPROVED BY
MEDSAFE
IN NEW ZEALAND
* AMARIN - ACTIVELY ENGAGING WITH POTENTIAL
COMMERCIALIZATION
PARTNERS IN NEW ZEALAND TO SUPPORT INTRODUCTION OF VAZKEPA
ACROSS NEW ZEALAND MARKET
Source text for Eikon: ID:nGNX38VT3x
Further company coverage: AMRN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Amarin
See all newsAmarin Corporation PLC reports results for the quarter ended June 30 - Earnings Summary
Ireland's Amarin Q2 revenue falls on lower licensing payments
Amarin Corporation PLC expected to post a loss of 1 cent a share - Earnings Preview
US Supreme Court backs generic drugmaker in 'skinny label' patent case (updated)
US Supreme Court backs generic drugmaker in 'skinny label' patent case